美国FDA药品数据库(U.S. FDA Drugs Database)
检索条件:" 药品名称=EMTRICITABINE"
商品名 申请号 产品号 申请类型 活性成分 剂型/给药途径 规格/剂量 RLD RS 申请号原始批准/暂定批准日期 产品号批准日期 申请人 市场状态
EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE 211640 001 ANDA EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE TABLET;ORAL 100MG;150MG No No 2023/03/09 2023/03/09 AUROBINDO PHARMA LTD Prescription
EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE 211640 002 ANDA EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE TABLET;ORAL 133MG;200MG No No 2023/03/09 2023/03/09 AUROBINDO PHARMA LTD Prescription
EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE 211640 003 ANDA EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE TABLET;ORAL 167MG;250MG No No 2023/03/09 2023/03/09 AUROBINDO PHARMA LTD Prescription
EMTRICITABINE 079188 001 ANDA EMTRICITABINE CAPSULE;ORAL 200MG No No 2023/03/15 2023/03/15 AUROBINDO PHARMA LTD Prescription
DOLUTEGRAVIR, EMTRICITABINE and TENOFOVIR ALAFENAMIDE 215448 001 NDA DOLUTEGRAVIR, EMTRICITABINE and TENOFOVIR ALAFENAMIDE TABLET; ORAL 50MG/200MG/25MG No No 2023/05/26 (TA) -- AUROBINDO PHARMA USA None (Tentative Approval)
EFAVIRENZ; EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE 201802 001 ANDA EFAVIRENZ; EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE TABLET;ORAL 600MG;200MG;300MG No No 2023/10/03 2023/10/03 STRIDES PHARMA Discontinued
EFAVIRENZ; EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE 201802 002 ANDA EFAVIRENZ; EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE TABLET;ORAL 300MG No No 2023/10/03 -- STRIDES PHARMA Prescription
EFAVIRENZ; EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE 201802 003 ANDA EFAVIRENZ; EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE TABLET;ORAL 600MG No No 2023/10/03 -- STRIDES PHARMA Prescription
EMTRICITABINE AND TENOFOVIR ALAFENAMIDE 211148 001 ANDA EMTRICITABINE, TENOFOVIR ALAFENAMIDE TABLET; ORAL 10MG No No 2024/01/02 (TA) -- MYLAN LABS LTD None (Tentative Approval)
EMTRICITABINE AND TENOFOVIR ALAFENAMIDE 211148 002 ANDA EMTRICITABINE, TENOFOVIR ALAFENAMIDE TABLET; ORAL 15MG No No 2024/01/02 (TA) -- MYLAN LABS LTD None (Tentative Approval)
EMTRICITABINE AND TENOFOVIR ALAFENAMIDE 211148 003 ANDA EMTRICITABINE, TENOFOVIR ALAFENAMIDE TABLET; ORAL 25MG No No 2024/01/02 (TA) -- MYLAN LABS LTD None (Tentative Approval)
EMTRICITABINE AND TENOFOVIR ALAFENAMIDE 211148 004 ANDA EMTRICITABINE, TENOFOVIR ALAFENAMIDE TABLET; ORAL 120MG No No 2024/01/02 (TA) -- MYLAN LABS LTD None (Tentative Approval)
EMTRICITABINE AND TENOFOVIR ALAFENAMIDE 211148 005 ANDA EMTRICITABINE, TENOFOVIR ALAFENAMIDE TABLET; ORAL 200MG No No 2024/01/02 (TA) -- MYLAN LABS LTD None (Tentative Approval)
EFAVIRENZ, EMTRICITABINE AND TENOFOVIR ALAFENAMIDE 213509 001 NDA EFAVIRENZ, EMTRICITABINE AND TENOFOVIR ALAFENAMIDE TABLET; ORAL 400MG; 200MG; 25MG No No 2024/03/22 (TA) -- MYLAN None (Tentative Approval)
EMTRICITABINE AND TENOFOVIR ALAFENAMIDE FUMARATE 214053 001 ANDA EMTRICITABINE; TENOFOVIR ALAFENAMIDE FUMARATE TABLET;ORAL 120MG;EQ 15MG BASE No No 2024/05/17 2024/05/17 APOTEX Discontinued
EMTRICITABINE AND TENOFOVIR ALAFENAMIDE FUMARATE 214053 002 ANDA EMTRICITABINE; TENOFOVIR ALAFENAMIDE FUMARATE TABLET;ORAL 200MG;EQ 25MG BASE No No 2024/05/17 2024/05/17 APOTEX Discontinued
EMTRICITABINE; TENOFOVIR ALAFENAMIDE 215071 001 ANDA EMTRICITABINE;TENOFOVIR ALAFENAMIDE TABLET;ORAL 200MG;25MG No No 2024/07/29 (TA) -- LUPIN LTD None (Tentative Approval)
EFAVIRENZ; EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE 209061 001 ANDA EFAVIRENZ; EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE TABLET;ORAL 600MG;200MG;300MG No No 2024/09/05 2024/09/05 MYLAN Discontinued
EMTRICITABINE AND TENOFOVIR ALAFENAMIDE FUMARATE 213926 001 ANDA EMTRICITABINE; TENOFOVIR ALAFENAMIDE FUMARATE TABLET;ORAL 200MG;EQ 25MG BASE No No 2024/12/13 -- LUPIN LTD Prescription
药品名称,活性成分,申请号搜索 高级检索
©2006-2024 DrugFuture->U.S. FDA Drugs Database